Atypical hemolytic uremic syndrome in the Tunisian population

International Urology and Nephrology

Volumn 43, Issue 2, 2011, Pages 559-564

  Leban, Nadia ^a   Aloui, Sabra ^b   Touati, Dalel ^b   Lakhdhar, Ramzy ^a   Skhiri, Habib ^b   Lefranc, Gerard ^c   Achour, Abdellatif ^d   Elmay, Mezri ^b   Lopez Trascasa, Margarita ^e   Sanchez Corral, Pilar ^e   Chibani, Jemni ^a   Haj Khelil, Amel ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c INSTITUTE OF HUMAN GENETICS   (France)

^d University Hospital of Sahloul   (Tunisia)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Atypical hemolytic uremic syndrome; Complement system; Tunisian population

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; CYCLOPHOSPHAMIDE; STEROID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AWARENESS; CASE REPORT; CLINICAL FEATURE; COMPLEMENT DEFICIENCY; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC DISORDER; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROLOGIST; PATHOGENESIS; PLASMAPHERESIS; REGULATOR GENE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TUNISIA; UNIVERSITY HOSPITAL;

ADULT; COMPLEMENT SYSTEM PROTEINS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUNISIA;

EID: 79959737835     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-010-9754-3     Document Type: Article

References (28)

1. Besbas N, Karpman D, Landau D et al (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423-431 (Pubitemid 44141568)
2. Noris M, Remuzzi G (2005) Hemolytic Uremic Syndrome. J Am Soc Nephrol 16:1035-1050 (Pubitemid 41710314)
3. Joel L, Moake MD (2002) Thrombotic microangiopathies. N Eng J Med 347(8):589-600
4. Sellier-Leclerc AL, Frémeaux-Bacchi V, Dragon-Durey MA et al (2007) Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18:2392-2400 (Pubitemid 47203855)
5. Ghazi O and Tadmouri GO (2005) Hemolytic-uremic syndrome. Centre for Arab Genomic Studies CTGA database 1-3
6. Warwicker P, Donne RL, Goodship THJ et al (1999) Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency. Nephrol Dial Transplant 14(5):1229-1233 (Pubitemid 29209312)
7. Noris M, Brioschi S, Caprioli J et al (2003) International registry of recurrent and familial HUS/TTP. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362(9395):1542-1547
8. Lutz HU, Jelezarova E (2006) Complement amplification revisited. Mol Immunol 43:2-12 (Pubitemid 41021518)
9. Frémeaux-Bacchi V, Miller EC, Liszewski MK et al (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112:4948-4952
10. Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J et al (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. PNAS 104:240-245 (Pubitemid 46068016)
11. Pérez-Caballero D, González-Rubio C, Gallardo ME et al (2001) Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 68(2):478-484 (Pubitemid 32147816)
12. Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361(17):1676-1687
13. Dragon-Durey MA, Loirat C, Cloarec S et al (2005) Anti-FH autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16(2):555-563 (Pubitemid 41725154)
14. Pickering MC, Cook HT (2008) Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol 151:210-230
15. Esparza-Gordillo J, Goicoechea de Jorge E, Abarrategui Garrido C et al (2006) Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree. Mol Immunol 43:1769-1775
16. Noris M, Brioschi S, Caprioli J et al (2003) Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362:1542-1547 (Pubitemid 37410193)
17. Richards A, Kemp EJ, Liszewski MK et al (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100:12966-12971 (Pubitemid 37340009)
18. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J et al (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41:84
19. Kavanagh D, Kemp EJ, Mayland E et al (2005) Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:2150-2155 (Pubitemid 41716447)
20. Richards A, Kathryn Liszewski M, Kavanagh D et al (2007) Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Mol Immunol 44:111-122 (Pubitemid 44754841)
21. Kavanagh D, Richards A, Fremeaux-Bacchi V et al (2007) Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2:591-596
22. Rougier N, Kazatchkine MD, Rougier JP et al (1998) Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 9(12):2318-2326 (Pubitemid 28543810)
23. Caprioli J, Noris M, Brioschi S et al (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267-1279 (Pubitemid 44232024)
24. Donne RL, Abbs I, Barany P et al (2002) Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. Am J Kidney Dis 40:E22
25. Amadei N, Baracho GV, Nudelman V et al (2001) Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H. Scand J Immunol 53(6):615-621 (Pubitemid 32575076)
26. Carreras L, Romero R, Requesens C et al (1981) Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3, B7 haplotype. JAMA 245:602-604 (Pubitemid 11141837)
27. Sánchez-Corral P, Pérez-Caballero D, Huarte O et al (2002) Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 71(6):1285-1295 (Pubitemid 36015883)
28. Bresin E, Daina E, Noris M et al (2006) Outcome of renal transplantation in patients with non-shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 1:88-99